Search research articles
Contact Us
Filters
Showing results (101-110 of 272) with videos related to
Page
of 28
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes
Joseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
P A Carpenter, S Pavlovic, J Y Tso, et al.
Blood
|
February 1, 1987
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
O W Press, F Appelbaum, J A Ledbetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission
Franz Buchegger, Cristian Antonescu, Claudine Helg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
F Buchegger, J-P Mach, O W Press, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246
O W Press, M LeBlanc, T J O'Rourke, et al.
ACS Applied Materials & Interfaces
|
March 10, 2015
Temozolomide nanoparticles for targeted glioblastoma therapy
Chen Fang, Kui Wang, Zachary R Stephen, et al.
Bone Marrow Transplantation
|
April 25, 2006
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
K Lilleby, P Garcia, T Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2006
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Bioconjugate Chemistry
|
January 20, 2005
Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma
Kevin J Hamblett, Oliver W Press, Damon L Meyer, et al.
Page
of 28
Search research articles
Search
Showing results (101-110 of 272) with videos related to
Sort By:
Page
of 28
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes
Joseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2000
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
P A Carpenter, S Pavlovic, J Y Tso, et al.
Blood
|
February 1, 1987
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
O W Press, F Appelbaum, J A Ledbetter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission
Franz Buchegger, Cristian Antonescu, Claudine Helg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2013
Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
F Buchegger, J-P Mach, O W Press, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246
O W Press, M LeBlanc, T J O'Rourke, et al.
ACS Applied Materials & Interfaces
|
March 10, 2015
Temozolomide nanoparticles for targeted glioblastoma therapy
Chen Fang, Kui Wang, Zachary R Stephen, et al.
Bone Marrow Transplantation
|
April 25, 2006
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
K Lilleby, P Garcia, T Gooley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2006
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
Bioconjugate Chemistry
|
January 20, 2005
Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma
Kevin J Hamblett, Oliver W Press, Damon L Meyer, et al.
Page
of 28